{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Anti-cancer", "Ayurveda", "Drugs and cosmetics act", "Schedule E1", "Toxic medicinal plants"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35661925", "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "05", "Day": "31"}], "Language": ["eng"], "ELocationID": ["100545", "10.1016/j.jaim.2022.100545", "S0975-9476(22)00004-3"], "Journal": {"ISSN": "0975-9476", "JournalIssue": {"Volume": "13", "Issue": "2", "PubDate": {"Year": "2022", "Season": "Apr-Jun"}}, "Title": "Journal of Ayurveda and integrative medicine", "ISOAbbreviation": "J Ayurveda Integr Med"}, "ArticleTitle": "Anti-cancer activities of Schedule E1 drugs used in ayurvedic formulations.", "Pagination": {"StartPage": "100545", "MedlinePgn": "100545"}, "Abstract": {"AbstractText": ["Schedule E1 is an important part of Drugs and Cosmetics Act (Government of India) that comprises the list of poisonous drugs from plant, animal and mineral origins to be consumed under medical supervision. Ayurveda, the world's oldest medicinal system has a list of drugs represented in schedule E1 that are used since thousands of years. This review reports the anti-cancer activities of fifteen toxic ayurvedic drugs from plant origin represented in Drugs and Cosmetics Act, 1940. The information was collected from the various authentic sources, compiled and summarised. The plant extracts, formulations, phytoconstituents and other preparations of these drugs have shown effective activities against mammary carcinoma, neuroblastoma, non-small cell lung carcinoma, lymphocytic leukaemia, colorectal adenocarcinoma, Ehrlich ascites carcinoma, prostate adenocarcinoma, glioblastoma asterocytoma and other malignancies. They have various mechanisms of action including Bax upregulation, Bcl<sub>2</sub> downregulation, induction of cell cycle arrest at S phase, G2/M phase, inhibition of vascular endothelial growth factors, inhibition of Akt/mTOR signalling etc. Certain traditional ayurvedic preparations containing these plants are reported beneficial and the possibilities of these drugs as the alternative and adjuvant therapeutic agents in the current cancer care have been discussed. The studies suggest that these drugs could be utilised in future for the critical care of malignancies."], "CopyrightInformation": "Copyright \u00a9 2022 The Authors. Published by Elsevier B.V. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Kancheepuram (Dt.), Tamilnadu 603203, India."}], "LastName": "Vikram", "ForeName": "E N T", "Initials": "ENT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Captain Srinivasa Murthy Central Ayurveda Research Institute, Central Council for Research in Ayurvedic Sciences, Ministry of AYUSH, Arumbakkam, Chennai, Tamilnadu 600106, India."}], "LastName": "Ilavarasan", "ForeName": "R", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Kancheepuram (Dt.), Tamilnadu 603203, India. Electronic address: monishakamaraj@gmail.com."}], "LastName": "Kamaraj", "ForeName": "R", "Initials": "R"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Ayurveda Integr Med", "NlmUniqueID": "101551404", "ISSNLinking": "0975-9476"}}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Institute N.C.  2021. What is cancer?https://www.cancer.gov/about-cancer/understanding/what-is-cancer"}, {"Citation": "Prashant M, Krishnan S, Meesha C, Priyanka D, Kondalli L S, Stephen S, et\u00a0al. Cancer statistics, 2020: report from National Cancer Registry Programme, India. JCO Global Oncol 6:1063\u20131075.", "ArticleIdList": ["PMC7392737", "32673076"]}, {"Citation": "Mallath M.K., Taylor D.G., Badwe R.A., Rath G.K., Shanta V., Pramesh C.S., et al. The growing burden of cancer in India: epidemiology and social context. Lancet Oncol. 2014;15:e205\u2013e212. doi: 10.1016/S1470-2045(14)70115-9.", "ArticleIdList": ["10.1016/S1470-2045(14)70115-9", "24731885"]}, {"Citation": "Hyuna S., Jacques F., Rebecca L.S., Mathieu L., Isabelle S., Ahmedin J., et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u2013249.", "ArticleIdList": ["33538338"]}, {"Citation": "Siegel R.L., Miller K.D., Fuchs H.E., Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71:7\u201333. doi: 10.3322/caac.21654.", "ArticleIdList": ["10.3322/caac.21654", "33433946"]}, {"Citation": "Swami Sadha Shiva Tirtha . Ayurveda Holistic Center Press; 2005. The ayurveda encyclopedia; p. 3."}, {"Citation": "Drugs and Cosmetics Act and Rules . Government of India, Ministry Of Health And Family Welfare; 1940. Schedule E (1), Rule 161(2) p. 317."}, {"Citation": "Drugs and Cosmetics Act and Rules . Government of India, Ministry Of Health And Family Welfare; 1945. Schedule E (1), Rule 161(2) p. 300."}, {"Citation": "Deore S.L., Moon K.V., Khadabadi S.S., Deokate U.A., Baviskar B.A. Evaluation of toxicity of \u2018Vatsanabha\u2019 (Aconitum ferox, Ranunculaceae) before and after Shodhana. J\u00a0Young Pharm. 2013;5:3\u20136. doi: 10.1016/j.jyp.2013.01.001.", "ArticleIdList": ["10.1016/j.jyp.2013.01.001", "PMC3758080", "24023444"]}, {"Citation": "Rastogi S. A\u00a0review of Aconite (Vatsanabha) usage in Ayurvedic formulations: traditional views and their inferences. Spat DD \u2013 Peer Rev J Complement Med Drug Discov. 2011;1:233. doi: 10.5455/spatula.20111220112858.", "ArticleIdList": ["10.5455/spatula.20111220112858"]}, {"Citation": "Hao Da Cheng, Gu Xiao-Jie, Xiao Pei Gen. Elsevier; 2015. Medicinal plants: chemistry, biology and omics; p. 217."}, {"Citation": "DeBono A., Capuano B., Scammells P.J. Progress toward the development of noscapine and derivatives as anticancer agents. J\u00a0Med Chem. 2015;58:5699\u20135727.", "ArticleIdList": ["25811651"]}, {"Citation": "Sajadian S., Vatankhah M., Majdzadeh M., Kouhsari S.M., Ghahremani M.H., Ostad S.N. Cell cycle arrest and apoptogenic properties of opium alkaloids noscapine and Papaverine on breast cancer stem cells. Toxicol Mech Methods. 2015;25:388\u2013395.", "ArticleIdList": ["25980655"]}, {"Citation": "Guler D., Ayd\u0131n A., Koyuncu M., Parmaks\u0131z \u0130., Tekin \u015e. Anticancer activity of papaver somniferum L. J\u00a0Turk Chem Soc \u2013 Sec A. 2016;3(3):349\u2013366."}, {"Citation": "Inada M., Shindo M., Kobayashi K., Sato A., Yamamoto Y., Akasaki Y., et al. Anticancer effects of a non-narcotic opium alkaloid medicine, Papaverine, in human glioblastoma cells. PLoS One. 2019;14(5) doi: 10.1371/journal.pone.0216358.", "ArticleIdList": ["10.1371/journal.pone.0216358", "PMC6524804", "31100066"]}, {"Citation": "Winzer T., Gazda V., He Z., Kaminski F., Kern M., Larson T.R., et al. A\u00a0papaver somniferum 10-gene cluster for synthesis of the anticancer alkaloid noscapine. Science. 2012;336(6089):1704\u20131708. doi: 10.1126/science.1220757.", "ArticleIdList": ["10.1126/science.1220757", "22653730"]}, {"Citation": "Carr G.  University of Hawaii, Dept. of Botany; 2003. Manoa campus plants.htpp://www.botany.hawaii.edu/faculty/carr/160webindex.htm Available on."}, {"Citation": "Habib M.R., Karim M.R. Evaluation of antitumour activity of Calotropis gigantea L. root bark against Ehrlich ascites carcinoma in Swiss albino mice. Asian Pac J Trop Med. 2011:786\u2013790.", "ArticleIdList": ["22014733"]}, {"Citation": "Jacinto S.D., Chun E.A.C. Cytotoxic cardenolide and sterols from Calotropis gigantea. Nat Prod Commun. 2011;6(6):803\u2013806.", "ArticleIdList": ["21815415"]}, {"Citation": "Habib M.R., Karim M.R. Antitumour evaluation of di-(2-ethylhexyl) phthalate (DEHP) isolated from Calotropis gigantea L. flower. Acta Pharm. 2012;62:607\u2013615.", "ArticleIdList": ["23333892"]}, {"Citation": "Mutiah R., Widyawaruyanti A., Sukardiman S. Ethyl acetate fraction of Calotropis gigantea roots induce apoptosis through increased G2/M and increased expression of caspase-8 in colon cancer WiDr cell line. J\u00a0Appl Pharmaceut Sci. 2017;7(7):197\u2013201."}, {"Citation": "Mutiah R, Widyawaruyanti A, Sukardiman S, Calotroposid A: A glycosides terpenoids from Calotropis gigantea induces apoptosis of colon cancer WiDr cells through cell cycle arrest G2/M and caspase 8 expression, Asian Pac J Cancer Prev APJCP, 19 (6), 1457-1464.", "ArticleIdList": ["PMC6103559", "29936715"]}, {"Citation": "Mutiah R., Widyawaruyanti A., Sukardiman S. Calotropis gigantea leaf extract increases the efficacy of 5-fluorouracil and decreases the efficacy of doxorubicin in widr colon cancer cell culture. J\u00a0Appl Pharmaceut Sci. 2018;8(4):51\u201356."}, {"Citation": "Mutiah R., Griana T.P., Ula Q.N., Andhyarto Y. The effect of Calotropis gigantea leaves extract on fibrosarcoma growth and caspase 3 expression. Int J Pharmaceut Chem Res. 2016;8(3):167\u2013171."}, {"Citation": "Bhat K.S., Sharma A., Venkatramana D.K. Antiproliferative effect of Calotropis gigantea (L.) R. BR. on breast cancer cells MCF-7. Int J Pharmaceut Sci Res. 2014;5(9):3918\u20133923."}, {"Citation": "Damodaran B., Nagaraja P., Jain V., Manuja Viraj Wimalasiri M.P., Sankolli G.M., Kumar G.V., et al. Phytochemical screening and evaluation of cytotoxic activity of Calotropis gigantea leaf extract on MCF7, HeLa, and A549 cancer cell lines. J\u00a0Nat Sci Biol Med. 2019;10:131\u2013138."}, {"Citation": "Premalatha B., Muthulakshmi V., Sachdanandam P. Anticancer potency of the milk extract of Semecarpus anacardium Linn. Nuts against aflatoxin B1 mediated hepatocellular carcinoma bearing wistar rats with reference to tumour marker enzymes. Phytother Res. 1999;13:183\u2013187.", "ArticleIdList": ["10353153"]}, {"Citation": "Mathivadhani P., Shanthi P., Sachdanandam P. Apoptotic effect of Semecarpus anacardium nut extract on T47D breast cancer cell line. Cell Biol Int. 2007;31:1198\u20131206.", "ArticleIdList": ["17572113"]}, {"Citation": "Arulkumaran S., Ramprasath V.R., Shanthi P., Sachdanandam P. Alteration of DMBA-induced oxidative stress by additive action of a modified indigenous preparation-- Kalpaamruthaa. Chem Biol Interact. 2007;167:99\u2013106.", "ArticleIdList": ["17349985"]}, {"Citation": "Sugapriya D., Shanthi P., Sachdanandam P. Restoration of energy metabolism in leukemic mice treated by a siddha drug: Semecarpus anacardium Linn. nut milk extract. Chem Biol Interact. 2008;173:43\u201358.", "ArticleIdList": ["18358458"]}, {"Citation": "Patel S.R., Suthan A.P., patel R.M. Invitro cytotoxicity activity of Semecarpus anacardium extract against Hep2 cell line and Vero cell line. Int J Pharm Tech Res. 2009;1(4):1429\u20131433."}, {"Citation": "Sowmyalakshmi S., Nur-E-Alam M., Akbarsha M.A., Thirugnanam S., Rohr J., chendil D. Investigation on Semecarpus anacardium L a siddha medicine for breast cancer. Planta. 2005;220(6):910\u2013918.", "ArticleIdList": ["15517350"]}, {"Citation": "Chitnis M.P., Bhatia K.G., Phatak M.K., Kesava Rao K.V. Anti-tumour activity of the extract of Semecarpus anacardium L. nuts in experimental tumor models. Indian J Exp Biol. 1980;18(1):6.", "ArticleIdList": ["7399581"]}, {"Citation": "Phatak M.K., Ambaye R.Y., Indap M.A., Bhatia K.G. Cytotoxicity of the acetylated oil of Semecarpus anacardium Linn. Indian J Phys Pharm. 1983;27(2):166.", "ArticleIdList": ["6885130"]}, {"Citation": "Indap M.A., Ambaye R.Y., Gokhale S.V. Antitumour and pharmacological effects of the oil from Semecarpus anacardium Linn. F. Indian J Physiol Pharmacol. 1983;27(2):83.", "ArticleIdList": ["6885136"]}, {"Citation": "Indap M.A., Ambaye R.Y., Gokhale S.V. Potentiation of activity of anti-cancer drugs by acetylated oil of Semecarpus anacardium Linn. F. in experimental tumours. Indian Drugs. 1986;23(8):447."}, {"Citation": "Kothari A.B., Lahiri M., Ghaisas S.D., Bhide S.V. In\u00a0vitro studies on antimutagenecity of water, alcoholic and oil extracts of Semecarpus anacardium. Indian J Pharmacol. 1997;29(5):301."}, {"Citation": "Smit H.F., Woerdenbag H.J., Singh R.H., Meulenbeld G.J., Labadie R.P., Zwaving J.H. Ayurvedic herbal drugs with possible cytostatic activity. J\u00a0Ethnopharmacol. 1995;47(2):75.", "ArticleIdList": ["7500639"]}, {"Citation": "Hembree J.A., Chang C.J., McLaughlin J.L., Peck G., Cassady J.M. The anticancer activity of Semecarpus anacardium. I.9 KB active pentadecylaccatechols. Lloydia. 1978;41(5):491.", "ArticleIdList": ["713709"]}, {"Citation": "Chakraborty S., Roy M., Taraphdar A.K., Bhattacharya R.K. Cytotoxic effect of root extract of Tiliacora racemosa and oil of Semecarpus anacardium Linn. nut in human tumour cells. Phytother Res. 2004;18(8):595.", "ArticleIdList": ["15476314"]}, {"Citation": "Sowmyalakshmi S., Nur-E-Alam M., Akbarsha M.A., Thirugnanam S., Rohr J., Chendil D. Investigation on Semecarpus Lehyam-a siddha medicine for breast cancer. Planta Med. 2005;220(6):910.", "ArticleIdList": ["15517350"]}, {"Citation": "Velasco G., Sanchez C., Guzman M. Endocannabinoids and cancer. Handb Exp Pharmacol. 2015;231:449\u2013472. doi: 10.1007/978-3-319-20825-1_16.", "ArticleIdList": ["10.1007/978-3-319-20825-1_16", "26408171"]}, {"Citation": "Demuth D.G., Molleman A. Cannabinoid signalling. Life Sci. 2006;78(6):549\u2013563. doi: 10.1016/j.lfs.2005.05.055.", "ArticleIdList": ["10.1016/j.lfs.2005.05.055", "16109430"]}, {"Citation": "Velasco G., Sanchez C., Guzman M. Anticancer mechanisms of can-nabinoids. Curr Oncol. 2016;23(Suppl 2):S23\u2013S32. doi: 10.3747/co.23.3080.", "ArticleIdList": ["10.3747/co.23.3080", "PMC4791144", "27022311"]}, {"Citation": "Perez-Gomez E., Andradas C., Blasco-Benito S., Caffarel M.M., Garcia-Taboada E., Villa-Morales, et al. Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer. J\u00a0Natl Cancer Inst. 2015;107(6):djv077. doi: 10.1093/jnci/djv077.", "ArticleIdList": ["10.1093/jnci/djv077", "25855725"]}, {"Citation": "Caffarel M.M., Andradas C., Mira E., Perez-Gomez E., Cerutti C., Moreno-Bueno G., et al. Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition. Mol Cancer. 2010;9:196. doi: 10.1186/1476-4598-9-196.", "ArticleIdList": ["10.1186/1476-4598-9-196", "PMC2917429", "20649976"]}, {"Citation": "Chung S.C., Hammarsten P., Josefsson A., Stattin P., Granfors T., Egevad L., et al. A\u00a0high cannabinoid CB1 receptor immunoreactivity is associated with disease severity and outcome in prostate cancer. Eur J Cancer. 2009;45(1):174\u2013182. doi: 10.1016/j.ejca.2008.10.010.", "ArticleIdList": ["10.1016/j.ejca.2008.10.010", "19056257"]}, {"Citation": "Cipriano M., Haggstrom J., Hammarsten P., Fowler C.J. Association between cannabinoid CB1 receptor expression and Akt signalling in prostate cancer. PLoS One. 2013;8(6) doi: 10.1371/journal.pone.0065798.", "ArticleIdList": ["10.1371/journal.pone.0065798", "PMC3673925", "23755281"]}, {"Citation": "Velasco G., Hernandez S., Davila D., Lorente M. The use of canna-binoids as anticancer agents. Prog Neuro-Psychopharmacol Biol Psychiatry. 2016;64:259\u2013266. doi: 10.1016/j.pnpbp.2015.05.010.", "ArticleIdList": ["10.1016/j.pnpbp.2015.05.010", "26071989"]}, {"Citation": "Thors L., Bergh A., Persson E., Hammarsten P., Stattin P., Egevad L., et al. Fatty acid amide hydrolase in prostate cancer: Association with disease severity and outcome, CB1 receptor expression and regulation by IL-4. PLoS One. 2010;5(8) doi: 10.1371/journal.pone.0012275.", "ArticleIdList": ["10.1371/journal.pone.0012275", "PMC2924377", "20808855"]}, {"Citation": "Sarfaraz S., Adhami V.M., Syed D.N., Afaq F., Mukhtar H. Cannabinoids for cancer treatment: progress and promise. Cancer Res. 2008;68(2):339\u2013342. doi: 10.1158/0008-5472.CAN-07-2785.", "ArticleIdList": ["10.1158/0008-5472.CAN-07-2785", "18199524"]}, {"Citation": "Orellana-Serradell O., Poblete C.E., Sanchez C., Castellon E.A., Gallegos I., Huidobro C., et al. Proapoptotic effect of endocannabinoids in prostate cancer cells. Oncol Rep. 2015;33(4):1599\u20131608. doi: 10.3892/or.2015.3746.", "ArticleIdList": ["10.3892/or.2015.3746", "PMC4358087", "25606819"]}, {"Citation": "Sanchez M.G., Sanchez A.M., Collado B., Malagarie-Cazenave S., Olea N., Carmena M.J., et al. Expression of the transient receptor potential vanilloid 1 (TRPV1) in LNCaP and PC-3 prostate cancer cells and in human prostate tissue. Eur J Pharmacol. 2005;515(1\u20133):20\u201327. doi: 10.1016/j.ejphar.2005.04.010.", "ArticleIdList": ["10.1016/j.ejphar.2005.04.010", "15913603"]}, {"Citation": "Pecze L., Josvay K., Blum W., Petrovics G., Vizler C., Olah Z., et al. Activation of endogenous TRPV1 fails to induce overstimulation-based cytotoxicity in breast and prostate cancer cells but not in pain-sensing neurons. Biochim Biophys Acta. 2016;1863(8):2054\u20132064. doi: 10.1016/j.bbamcr.2016.05.007.", "ArticleIdList": ["10.1016/j.bbamcr.2016.05.007", "27180305"]}, {"Citation": "De Petrocellis L., Ligresti A., Schiano Moriello A., Iappelli M., Verde R., Stott C.G., et al. Non-THC cannabinoids inhibit prostate carcinoma growth in\u00a0vitro and in\u00a0vivo: pro-apoptotic effects and underlying mechanisms. Br J Pharmacol. 2013;168(1):79\u2013102. doi: 10.1111/j.1476-5381.2012.02027.x.", "ArticleIdList": ["10.1111/j.1476-5381.2012.02027.x", "PMC3570006", "22594963"]}, {"Citation": "Pineiro R., Maffucci T., Falasca M. The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation. Oncogene. 2011;30(2):142\u2013152. doi: 10.1038/onc.2010.417.", "ArticleIdList": ["10.1038/onc.2010.417", "20838378"]}, {"Citation": "Mukhopadhyay B., Schuebel K., Mukhopadhyay P., Cinar R., Godlewski G., Xiong K., et al. Cannabinoid receptor 1 promotes hepatocellular carcinoma initiation and progression through multiple mechanisms. Hepatology. 2015;61(5):1615\u20131626. doi: 10.1002/hep.27686.", "ArticleIdList": ["10.1002/hep.27686", "PMC4406817", "25580584"]}, {"Citation": "Xu X., Liu Y., Huang S., Liu G., Xie C., Zhou J., et al. Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma. Cancer Genet Cytogenet. 2006;171(1):31\u201338. doi: 10.1016/j.cancergencyto.2006.06.014.", "ArticleIdList": ["10.1016/j.cancergencyto.2006.06.014", "17074588"]}, {"Citation": "Preet A., Qamri Z., Nasser M.W., Prasad A., Shilo K., Zou X., et al. Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis. Cancer Prev Res. 2011;4(1):65\u201375. doi: 10.1158/1940-6207.CAPR-10-0181.", "ArticleIdList": ["10.1158/1940-6207.CAPR-10-0181", "PMC3025486", "21097714"]}, {"Citation": "Freund P., Porpaczy E.A., Le T., Gruber M., Pausz C., Staber P., et al. Cannabinoid receptors are overexpressed in CLL but of limited potential for therapeutic exploitation. PLoS One. 2016;11(6) doi: 10.1371/journal.pone.0156693.", "ArticleIdList": ["10.1371/journal.pone.0156693", "PMC4889125", "27248492"]}, {"Citation": "Michalski C.W., Oti F.E., Erkan M., Sauliunaite D., Bergmann F., Pacher P., et al. Cannabinoids in pancreatic cancer: correlation with survival and pain. Int J Cancer. 2008;122(4):742\u2013750. doi: 10.1002/ijc.23114.", "ArticleIdList": ["10.1002/ijc.23114", "PMC2225529", "17943729"]}, {"Citation": "Chakravarti B., Ravi J., Ganju R.K. Cannabinoids as therapeutic agents in cancer: current status and future implications. Oncotarget. 2014;5(15):5852\u20135872. doi: 10.18632/oncotarget.2233.", "ArticleIdList": ["10.18632/oncotarget.2233", "PMC4171598", "25115386"]}, {"Citation": "Carracedo A., Gironella M., Lorente M., Garcia S., Guzman M., Velasco G., et al. Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes. Cancer Res. 2006;66(13):6748\u20136755. doi: 10.1158/0008-5472.CAN-06-0169.", "ArticleIdList": ["10.1158/0008-5472.CAN-06-0169", "16818650"]}, {"Citation": "Zhao Z., Yang J., Zhao H., Fang X., Li H. Cannabinoid receptor 2 is upregulated in melanoma. J\u00a0Cancer Res Therapeut. 2012;8(4):549\u2013554. doi: 10.4103/0973-1482.106534.", "ArticleIdList": ["10.4103/0973-1482.106534", "23361273"]}, {"Citation": "Cridge B.J., Rosengren R.J. Critical appraisal of the potential use of cannabinoids in cancer management. Cancer Manag Res. 2013;5:301\u2013313. doi: 10.2147/CMAR.S36105.", "ArticleIdList": ["10.2147/CMAR.S36105", "PMC3770515", "24039449"]}, {"Citation": "Hart S., Fischer O.M., Ullrich A. Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor. Cancer Res. 2004;64(6):1943\u20131950. doi: 10.1158/0008-5472.CAN-03-3720.", "ArticleIdList": ["10.1158/0008-5472.CAN-03-3720", "15026328"]}, {"Citation": "Shrivastava A., Kuzontkoski P.M., Groopman J.E., Prasad A. Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy. Mol Cancer Therapeut. 2011;10(7):1161\u20131172. doi: 10.1158/1535-7163.MCT-10-1100.", "ArticleIdList": ["10.1158/1535-7163.MCT-10-1100", "21566064"]}, {"Citation": "Solinas M., Massi P., Cinquina V., Valenti M., Bolognini D., Gariboldi M., et al. Cannabidiol, a non-psychoactive cannabinoid compound, inhibits proliferation and invasion in U87-MG and T98G glioma cells through a multitarget effect. PLoS One. 2013;8(10) doi: 10.1371/journal.pone.0076918.", "ArticleIdList": ["10.1371/journal.pone.0076918", "PMC3804588", "24204703"]}, {"Citation": "Sharma M., Hudson J., Adomat H., Guns E., Cox M. In\u00a0vitro anticancer activity of plant-derived cannabidiol on prostate cancer cell lines. Pharmacol Pharm. 2014;5(8):806\u2013820. doi: 10.4236/pp.2014.58091.", "ArticleIdList": ["10.4236/pp.2014.58091"]}, {"Citation": "Marcu J.P., Christian R.T., Lau D., Zielinski A.J., Horowitz M.P., Lee J., et al. Cannabidiol enhances the inhibitory effects of delta9-tetrahy-drocannabinol on human glioblastoma cell proliferation and survival. Mol Cancer Therapeut. 2010;9(1):180\u2013189. doi: 10.1158/1535-7163.MCT-09-0407.", "ArticleIdList": ["10.1158/1535-7163.MCT-09-0407", "PMC2806496", "20053780"]}, {"Citation": "Nagarkatti P., Pandey R., Rieder S.A., Hegde V.L., Nagarkatti M. Cannabinoids as novel anti-inflammatory drugs. Future Med Chem. 2009;1(7):1333\u20131349. doi: 10.4155/fmc.09.93.", "ArticleIdList": ["10.4155/fmc.09.93", "PMC2828614", "20191092"]}, {"Citation": "McKallip R.J., Nagarkatti M., Nagarkatti P.S. \u0394-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response. J\u00a0Immunol. 2005;174(6):3281\u20133289. doi: 10.4049/jimmunol.174.6.3281.", "ArticleIdList": ["10.4049/jimmunol.174.6.3281", "15749859"]}, {"Citation": "Zhu L.X., Sharma S., Stolina M., Gardner B., Roth M.D., Tashkin D.P., et al. \u0394-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway. J\u00a0Immunol. 2000;165(1):373\u2013380. doi: 10.4049/jimmunol.165.1.373.", "ArticleIdList": ["10.4049/jimmunol.165.1.373", "10861074"]}, {"Citation": "Castaneto M.S., Gorelick D.A., Desrosiers N.A., Hartman R.L., Pirard S., Huestis M.A. Synthetic cannabinoids: epidemiology, pharma-codynamics, and clinical implications. Drug Alcohol Depend. 2014;144:12\u201341. doi: 10.1016/j.drugalcdep.2014.08.005.", "ArticleIdList": ["10.1016/j.drugalcdep.2014.08.005", "PMC4253059", "25220897"]}, {"Citation": "Debruyne D., Le Boisselier R. Emerging drugs of abuse: current perspectives on synthetic cannabinoids. Subst Abuse Rehabil. 2015;6:113\u2013129. doi: 10.2147/SAR.S73586.", "ArticleIdList": ["10.2147/SAR.S73586", "PMC4622447", "26543389"]}, {"Citation": "Romano B., Pagano E., Orlando P., Capasso R., Cascio M.G., Pertwee R., et al. Pure delta9-tetrahydrocannabivarin and a Cannabis sativa extract with high content in delta9-tetrahydrocannabivarin inhibit nitrite production in murine peritoneal macrophages. Pharmacol Res. 2016;113(Pt A):199\u2013208. doi: 10.1016/j.phrs.2016.07.045.", "ArticleIdList": ["10.1016/j.phrs.2016.07.045", "27498155"]}, {"Citation": "Ke Y., Ye K., Grossniklaus H.E., Archer D.R., Joshi H.C., Kapp J.A. Noscapine inhibits tumor growth with little toxicity to normal tissues or inhibition of immune responses. Cancer Immunol Immunother. 2000;49:217\u2013225.", "ArticleIdList": ["10941904"]}, {"Citation": "Aneja R., Vangapandu S.N., Lopus M., Chandra R., Panda D., Joshi H.C. Development of a novel nitro-derivative of noscapine for the potential treatment of drug- resistant ovarian cancer and T-cell lymphoma. Mol Pharmacol. 2006;69:1801\u20131809.", "ArticleIdList": ["16517755"]}, {"Citation": "Aneja R., Zhou J., Vangapandu S.N., Zhou B., Chandra R., Joshi H.C. Drug-resistant T-lymphoid tumors undergo apoptosis selectively in response to an antimicrotubule agent, EM011. Blood. 2006;107:2486\u20132492.", "ArticleIdList": ["PMC1895738", "16282340"]}, {"Citation": "Aneja R., Zhou J., Zhou B., Chandra R., Joshi H.C. Treatment of hormone-refractory breast cancer: apoptosis and regression of human tumors implanted in mice. Mol Cancer Therapeut. 2006;5:2366\u20132377.", "ArticleIdList": ["16985071"]}, {"Citation": "Aneja R., Lopus M., Zhou J., Vangapandu S.N., Ghaleb A., Yao J., et al. Rational design of the microtubule-targeting anti-breast cancer drug EM015. Cancer Res. 2006;66:3782\u20133791.", "ArticleIdList": ["16585205"]}, {"Citation": "Landen J.W., lang R., McMahon S.J., Rusan N.M., Yvon A.M., Adams A.W., et al. Noscapine alters microtubule dynamics in living cells and inhibits the progression of melanoma. Cancer Res. 2002;62:4109\u20134114.", "ArticleIdList": ["12124349"]}, {"Citation": "Zhou J., Gupta K., Aggarwal S., Aneja R., Panda R., Joshi H.C. Brominated derivatives of noscapine are potent microtubule interfering agents that perturb mitosis and inhibit cell proliferation. Mol Pharmacol. 2003;63:799\u2013807.", "ArticleIdList": ["12644580"]}, {"Citation": "Landen J.W., Hau V., Wang M., Davis T., Ciliax B., Wainer B.H., et al. Noscapine Crosses the blood-brain barrier and inhibits glioblastoma growth. Clin Cancer Res. 2004;10:5187\u20135201.", "ArticleIdList": ["15297423"]}, {"Citation": "Aneja R., Ghaleb A.M., Zhou J., Yang V.W., Joshi H.C. P53 and p21 determine the sensitivity of noscapine-induced apoptosis in colon cancer cells. Cancer Res. 2007;67:3862\u20133870.", "ArticleIdList": ["PMC3757339", "17440101"]}, {"Citation": "Jackson T., Chougule M.B., Ichite N., Patlolla R.R., Singh M. Antitumor activity of noscapine in human non-small cell lung cancer xenograft model. Cancer Chemother Pharmacol. 2008;63:117\u2013126.", "ArticleIdList": ["PMC7799395", "18338172"]}, {"Citation": "Guggisberg J., Schumacher M., Gilmore G., Zylla D.M. Cannabis as an anticancer agent: a review of clinical data and assessment of case reports. Cannabis Cannabinoid Res. 2021 Aug 7 doi: 10.1089/can.2021.0045. Epub ahead of print. PMID: 34370591.", "ArticleIdList": ["10.1089/can.2021.0045", "PMC8864433", "34370591"]}, {"Citation": "Seethalaxmi R., Saravana kumari P. In-vitro cytotoxic activity of Baliospermum Montanum leaves on cervical cancer- Hela cell lines and chemical characterization by GCMS. Int J Pharm Bio Sci. 2018;9(2):213\u2013220."}, {"Citation": "Ogura M., Koike K., Cordell G.A., Farnsworth N.R. Potential anticancer agents VIII. Constituents of Baliospermum montanum (Euphorbiaceae) Planta Med. 1978;33:128\u2013143.", "ArticleIdList": ["652863"]}, {"Citation": "Seethalakshmi R., Saravana Kumari P. In-vitro anticancer activity of Baliospermum montanum on T-cell leukemia- Jurkat cell line and Human Breast cancer MCF-7. IAETSD J Adv Sci Appl Sci. Jan 2018;5(1):173\u2013179."}, {"Citation": "Renugadevi K., Aswini V., Raji P. Microwave irradiation assisted synthesis of silver nanoparticle using leaf extract of Baliospermum montanum and evaluation of its antimicrobial, anticancer potential activity. Asian J Pharmaceut Clin Res. 2012;5(4):283\u2013287."}, {"Citation": "Pipatrattanaseree W., Itharat A., Mukkasombut N., Saesiw U. Potential in\u00a0vitro anti-allergic, anti-inflammatory and cytotoxic activities of ethanolic extract of Baliospermum montanum root, its major components and a validated HPLC method. BMC Compl Alternative Med. 2019;19:45. doi: 10.1186/s12906-019-2449-0.", "ArticleIdList": ["10.1186/s12906-019-2449-0", "PMC6373163", "30755219"]}, {"Citation": "Nandagaon V.S., Kulkarni A.R. In\u00a0vitro antioxidant and cytotoxicity activity of Bacopa monnieri and Baliospermum. Montanum Muell Arg. 2013;4:63\u201367."}, {"Citation": "Cherian A.M., Snima K.S., Kamath C.R., Nair S.V., Lakshmanan V.K. Effect of Baliospermum montanum nanomedicine apoptosis induction and antimigration of prostate cancer cells. Biomed Pharmacother. 2015;71:201\u2013209.", "ArticleIdList": ["25960237"]}, {"Citation": "Nuhu H. Alakaloid content of the leaves of three Nigerian Datura species Nig. J\u00a0Nat Prod Med. 2002;6:15\u201318."}, {"Citation": "Yusuf M., Begum J., Hoque M.N., Chowdhury J.U. BCSIR; Chittagong, Bangladesh: 2009. Medicinal plants of Bangladesh; p. 794."}, {"Citation": "Ma Lei, Xie Chuan-Ming, Li Jia, Lou Feng-Chang, Hu Li-Hong, Daturametelins H. I, and J: three new withanolide glycosides from Datura metel L. Chem Biodivers. 2006;3(2):180\u2013186.", "ArticleIdList": ["17193256"]}, {"Citation": "Pan Y., Wang X., Hu X. Cytotoxic withanolides from the flowers of Datura metel. J\u00a0Nat Prod. 2007;70:1127\u20131132.", "ArticleIdList": ["17583953"]}, {"Citation": "Nazeema Banu B., Julie J., Abirami J., Kumareasan R., Muthukumaran T., Rajasree S., et al. Anti-cancer activity of Datura metel on MCF-7 cell line. Asian J Pharmaceut Clin Res. 2014;7(Suppl 1):181\u2013183."}, {"Citation": "Bellila A., Tremblay C., Pichette A., Marzouk B., Mshvildadze V., Lavoie S., et al. Cytotoxic activity of withanolides isolated from Tunisian Datura metel L. Phytochemistry. 2011;72(16):2031\u20132036.", "ArticleIdList": ["21851957"]}, {"Citation": "Xue Juan, Sun Yichun, Qing Wei, Wang Changfu, Yang Bingyou, Kuang Haixue, et al. Chemical composition and cytotoxicity of the essential oil from different parts of Datura metel L. Nat Prod Res. 2015 doi: 10.1080/14786419.2015.1088541.", "ArticleIdList": ["10.1080/14786419.2015.1088541", "26418519"]}, {"Citation": "Kuriakose G.C., Singh S., Rajvanshi P.K., Surin W.R., Jayabaskaran C. In\u00a0vitro cytotoxicity and apoptosis induction in human cancer cells by culture extract of an endophytic Fusarium solani strain isolated from Datura metel L. Pharm Anal Acta. 2014;5:293. doi: 10.4172/2153-2435.1000293.", "ArticleIdList": ["10.4172/2153-2435.1000293"]}, {"Citation": "Okhale S.E., Nwanosike E.M. Abrus precatorius Linn (Fabaceae): phytochemistry, ethnomedicinal uses, ethnopharmacology and pharmacological activities. Int J Pharmaceut Sci Res. 2016;1(6):37\u201343."}, {"Citation": "Chaudhari K.S., Sharma Ramakant, Pawar P.S., Kashikar V.A. Pharmacological activities of Abrus precatorius Linn. - a review. Int J Ayurvedic Herbal Med. 2012;2(2):336\u2013348."}, {"Citation": "Lochan Kanjiv. Bhaisajya Ratnavali of Govinda Dasji Bhisagratna; Volume II, chapter 44, Verse 77, 80-81, Varanasi. Galaganda, editor. Chaukhamba Sanskrit Sansthan. 2009;719:724\u2013725."}, {"Citation": "Sofi M.S., Nabi S. Induction of caspase-3 dependent apoptosis, cell cycle arrest and cytotoxicity in breast cancer cells by Abrus precatorius. Int J Pharm Pharmaceut Sci. 2018;10(8):29\u201335."}, {"Citation": "Subba R.V.V., Sirsi M. Effect of Abrus precatorius L. on experimental tumors. Cancer Res. 1969;29:1447\u20131451.", "ArticleIdList": ["5799161"]}, {"Citation": "Siddiqi T.O., Bhupinder D., Peerzada S.H.K., Iqbal M. Angiospermous seeds of medicinal importance. J\u00a0Econ Taxon Bot. 2001;25:101."}, {"Citation": "Ramnath G.K., Ramadasan K. Antitumour effect of abrin on transplanted tumours in mice. Indian J Physiol Pharmacol. 2002;46:69\u201377.", "ArticleIdList": ["12024960"]}, {"Citation": "Sivakumar R., Alagesaboopathi C. Studies on cytotoxicity and antitumor screening of red and white forms of Abrus precatorius L. Afr J Biotechnol. 2008;7(22):3984\u20133988."}, {"Citation": "Harborne J.B. 2nd ed. Chapman & Hall; New York: 1984. Phytochemical methods."}, {"Citation": "Manjunath B.L., Ed. vol. 1. CSIR; New Delhi, India: 1948. (The wealth of India \u2013 raw materials)."}, {"Citation": "Gautam D.N.S., Dixit S.K., Benerji R., Malhrotra S. A\u00a0HPTLC study for assessment of sodhana effect on alkaloids of gunja (Abrus precatorius) Aryavaidyan. 2001;14:146\u2013153."}, {"Citation": "Sivakumar R. Bharathiar University; Coimbatore, Tamilnadu, India: 2002. Pharmacognostical, phytochemical and pharmacological studies on Abrus precatorius L. Ph.D. Thesis."}, {"Citation": "Subhadip M., Prashanta Kumar P., Durgesh Nandini D., Niharika S., Birendra B., Tapas Kumar M., et al. Abrus agglutinin suppresses human hepatocellular carcinoma in\u00a0vitro and in\u00a0vivo by inducing caspase mediated cell death. Acta Pharmacol Sin. 2014;35:814\u2013824. doi: 10.1038/aps.2014.15.", "ArticleIdList": ["10.1038/aps.2014.15", "PMC4086388", "24793310"]}, {"Citation": "Gul M.Z., Ahmad F., Kondapi A.K., Qureshi I.A., Ghazi I.A. Antioxidant and antiproliferative activities of Abrus precatorius leaf extracts - an in\u00a0vitro study. BMC Compl Alternative Med. 2013;13:53. http://www.biomedcentral.com/1472-6882/13/53", "ArticleIdList": ["PMC3600005", "23452983"]}, {"Citation": "Gul M.Z., Chandrasekaran S., Manjulatha K., Bhat M.Y., Maurya R., Qureshi I.A., et al. Anti proliferative and apoptosis inducing effects of Abrus precatorius against Human monocytic leukaemia (THP-1) Cell line. Indian J Pharmaceut Sci. 2018;80(2):307\u2013317."}, {"Citation": "Okoro E.E., Osoniyi O.R., Jabeen A., Shams S., Choudhary M.I., Onajobi F.D. Anti-proliferative and immunomodulatory activities of fractions from methanol root extract of Abrus precatorius L. Clinical Phytoscience. 2019;5:45. doi: 10.1186/s40816-019-0143-x.", "ArticleIdList": ["10.1186/s40816-019-0143-x"]}, {"Citation": "Sofi M.S., M. K., Sateesh M.K., Bashir M., Ganie M.A., Nabi S. Chemopreventive and anti-breast cancer activity of compounds isolated from leaves of Abrus precatorius L. 3 Biotech. 2018;8:371. doi: 10.1007/s13205-018-1395-8.", "ArticleIdList": ["10.1007/s13205-018-1395-8", "PMC6087508", "30105196"]}, {"Citation": "Oladimeji A.O., Babatunde O., Musa R.T., M\u2019civer F.A., Lawal A.T., Ogunwande I.A. GC-MS analysis and cytotoxic activity of essential oils from the leaves of Abrus precatorius L. Gaertn. Asian Pac J Trop Dis. 2016;6(5):372\u2013375."}, {"Citation": "Patil A., Vadera K., Patil D., Phatak A., Chandra N. Phytochemical analysis, in\u00a0vitro anticancer activity and HPTLC fingerprint profile of seeds of Abrus precatorius L. Int J Pharmaceut Sci Rev Res. 2015;33(1):262\u2013269."}, {"Citation": "L\u00e9bri M., Tilaoui M., Bahi C., Achibat H., Akhramez S., Fofi\u00e9 Y.B.N., et al. Phytochemical analysis and in\u00a0vitro anticancer effect of aqueous extract of Abrus precatorius Linn. Der Pharma Chem. 2015;7(8):112\u2013117."}, {"Citation": "Khalifa N S, El-Hallouty S M, Barakat H S, Salim D M, In\u00a0vitro cytotoxic and antioxidant activities of some plant extracts on different human cancer cell lines, 2013, Egypt. J Exp Biol (Bot), 9(1): 137 \u2013 144."}, {"Citation": "Qiu H.X. Science Press; Beijing, China: 1996. Flora of China; p. 133."}, {"Citation": "Wang X., Zhang F., Liu Z., Feng H., Yu Z.B., Lu Y., et al. Effects of essential oil from Croton tiglium L. on intestinal transit in mice. J\u00a0Ethnopharmacol. 2008;117:102\u2013107.", "ArticleIdList": ["18329205"]}, {"Citation": "Glaser S., Sorg B., Hecker E.A. Planta Med. 1988;54:580.", "ArticleIdList": ["17265380"]}, {"Citation": "El-Mekkawy S., Meselly M.R., Nakamura N., Hattori M., Kawahata T., Otake T. Chem Pharm Bull. 1999;47:1346.", "ArticleIdList": ["10517016"]}, {"Citation": "El-Mekkawy S., Meselly M.R., Nakamura N., Hattori M., Kawahata T., Otake T. Phytochemistry. 2000;53:457.", "ArticleIdList": ["10731023"]}, {"Citation": "Han T.Z., Zhu X.X., Yang R.Y., Sun J.Z., Tian G.F., LiU X.J., et al. Effect of intravenous infusions 12-O-tetradecanoylphorbol-13-acetate (TPA) in patients with myelocytic leukemia: preliminary studies on therapeutic efficacy and toxicity. Proc Natl Acad Sci Unit States Am. 1998;95:5357\u20135361.", "ArticleIdList": ["PMC20265", "9560280"]}, {"Citation": "Kim C.W., Moon J.C., Kim J.B. Cytotoxic effects of extract (cp-2) from the mixture of Coptis and Croton tiglium L. of the various tumor cell lines. Korean Cent J Med. 1993;58:177\u2013184."}, {"Citation": "Kim J.H., Lee S.J., Han Y.B., Moon J.J., Kim J.B. Isolation of isoguanosine from Croton tiglium and its antitumor activity. Arch Pharm Res. 1994;17:115\u2013118.", "ArticleIdList": ["10319142"]}, {"Citation": "Skipper H.E., Montgomery J.A., Thomson, Schabel F.M., Jr. Structural activity relations and cross resistance observed on evaluation of a series of purine analogs against experimental Neoplasms. Cancer Res. 1959;19:425\u2013437.", "ArticleIdList": ["13652127"]}, {"Citation": "Li Changyou, Wu Xiao, Sun Rongli, Zhao Peng, Liu Fengjuan, Zhang Chunling. Croton tiglium extract induces the apoptosis in human lung cancer A549 cells. J\u00a0Thorac Oncol. 2007;12(1):S1532. doi: 10.1016/j.jtho.2016.11.2120. Supplement.", "ArticleIdList": ["10.1016/j.jtho.2016.11.2120"]}, {"Citation": "Huberman E., Callaham M.F. Induction of terminal differentiation in human promyelocytic leukemia cells by tumor promoting agents. Proc Natl Acad Sci USA. 1979;76(3):1293\u20131297.", "ArticleIdList": ["PMC383237", "286311"]}, {"Citation": "Lotem J., Sachs L. Regulation of normal differentiation in mouse and human myeloid leukemic cells by phorbol esters and the mechanism of tumor promotion. Proc Natl Acad Sci USA. 1979;76(10):5158\u20135162.", "ArticleIdList": ["PMC413099", "291929"]}, {"Citation": "Rovera G., O'Brien T.G., Diamond L. Induction of differentiation in human promyelocytic leukemia cells by tumor promoters. Science (Wash DC) 1979;204(4395):868\u2013870.", "ArticleIdList": ["286421"]}, {"Citation": "Rovera G., Olashaw N., Meo P. Terminal differentiation in human promyelocytic leukemic cells in the absence of DNA synthesis. Nature (Lond) 1980;284:69\u201370.", "ArticleIdList": ["6928258"]}, {"Citation": "Garzotto M., White-Jones M., Jiang Y., Ehleiter D., Liao W.C., Haimovitz-Friedman A., et al. 12-O-tetradecanoylphorbol-13-acetate induced apoptosis in LNCaP cells is mediated through ceramide synthase. Cancer Res. 1998;58(10):2260\u20132264.", "ArticleIdList": ["9605775"]}, {"Citation": "Guilbaud N.F., Gas N., Dupont M.A., Valette A. Effects of differentiation-inducing agents on maturation of human MCF-7 breast cancer cells. J\u00a0Cell Physiol. 1990;145(1):162\u2013172.", "ArticleIdList": ["2211839"]}, {"Citation": "Arita Y., O'Driscoll K.R., Weinstein I.B. Growth inhibition of human melanoma-derived cells by 12-O-tetradecanoyl phorbol 13 acetate. Int J Cancer. 1994;56(2):229\u2013235.", "ArticleIdList": ["8314307"]}, {"Citation": "Salge U., Kilian P., Neumann K., Elsasser H.P., Havemann K., Heidtmann H.H. Differentiation capacity of human non-small-cell lung cancer cell lines after exposure to phorbol ester. Int J Cancer. 1990;45(6):1143\u20131150.", "ArticleIdList": ["1972142"]}, {"Citation": "Salge U., Kilian P., Neumann K., Elsasser H.P., Havemann K., Heidtmann H.H. Differentiation capacity of human non-small-cell lung cancer cell lines after exposure to phorbol ester. Int J Cance. 1990;45(6):1143\u20131150.", "ArticleIdList": ["1972142"]}, {"Citation": "Powell C.T., Brittis N.J., Stec D., Hug H., Heston W.D., Fair W.R. Persistent membrane translocation of protein kinase C alpha during 12-O-tetradecanoylphorbol-13-acetate-induced apoptosis of LNCaP human prostate human. Cell Growth Differ. 1996;7(4):419\u2013428.", "ArticleIdList": ["9052983"]}, {"Citation": "Fujii T., Garcia-Bermejo M.L., Bernabo J.L., Caamano J., Ohba M., Kuroki T. Involvement of protein kinase C delta (PKC delta) in phorbol ester-induced apoptosis in LNCaP prostate cancer cells. Lack of proteolytic cleavage of PKC delta. J\u00a0Biol Chem. 2000;275(11):7574\u20137582.", "ArticleIdList": ["10713064"]}, {"Citation": "Konno S., Hsieh T.C., Wu J.M., Chen Y., Chiao J.W., Mallouh C. Growth control of human prostate cancer cells by the phorbol ester TPA: possible involvement of protein kinases. Anticancer Res. 1996;16(4A):1843\u20131849.", "ArticleIdList": ["8712711"]}, {"Citation": "Zheng X., Chang R.L., Cui X.X., Avila G.E., Lee S., Lu Y.P., et al. Inhibitory effect of 12-O-tetradecanoylphorbol-13-acetate alone or in combination with all-trans-retinoic acid on the growth of LNCaP prostate tumors in immunodeficient mice. Cancer Res. 2004;64:1811\u20131820.", "ArticleIdList": ["14996744"]}, {"Citation": "Mizokami A., Gotoh A., Yamada H., Keller E.T., Matsumoto T. Tumor necrosis factor-\u03b1 represses androgen sensitivity in the LNCaP prostate cancer cell line. J\u00a0Urol. 2000;164(3 part 1):800\u2013805.", "ArticleIdList": ["10953159"]}, {"Citation": "Witcher M., Ross D.T., Rousseau C., Deluca L., Miller W.H., Jr. Synergy between all transretinoic acid and tumor necrosis factor pathways in acute leukemia cells. Blood. 2003;102:237\u2013245.", "ArticleIdList": ["12586626"]}, {"Citation": "Chambaut-Guerin A.M., Costa S.L., Lefrancois T., Fages C., Gauthereau X., Tardy M. Effects of retinoic acid and tumor necrosis factor-\u03b1 on GL-15 glioblastoma cells. Neuroreport. 2000;11:389\u2013393.", "ArticleIdList": ["10674492"]}, {"Citation": "Changyou Li, Xiao Wu, Rongli Sun, Peng Zhao, Fengjuan Liu, Chunling Zhang, Croton tiglium extract induces apoptosis via Bax/Bcl-2 pathways in human lung cancer A549 cells, Asian Pac J Cancer Prev APJCP, Vol 17, 4893-4898.", "ArticleIdList": ["PMC5454692", "28032492"]}, {"Citation": "Zhang X.L., Wang L., Li F., Yu K., Wang M.K. Cytotoxic phorbol esters of Croton tiglium. J\u00a0Nat Prod. 2013;76(5):858\u2013864.", "ArticleIdList": ["23701597"]}, {"Citation": "Junfeng Wang, Li Qin, Biqing Zhao, Liang Cai, Zhenping Zhong, Yonghong Liu, et\u00a0al, Two rare tigliane diterpenoid derivatives against K562 cells from Croton tiglium, Org Biomol Chem. DOI: 10.1039/c8ob02519c.", "ArticleIdList": ["30534799"]}, {"Citation": "A\u00a0brief history of the wondrous oleander plant-Part 3 of the oleander series. 2013. http://www.naturalnews.com/022949_Oleander_health_history.html# Available from: [Last cited on 2013 Feb 11]"}, {"Citation": "Nerium Biotechnology, Inc. 2013. http://www.Neriumbiotech.com/research.htm Available from: [Last cited on 2013 Feb 2]"}, {"Citation": "Sharma P.V. In: Cikitsasthana Ashtadashosadhyayah., editor. Chaukhamba Visvabharathi; Varanasi: 2010. Susruta-Samhita; Volume II Chapter XVII, Verse 37-42; pp. 444\u2013445."}, {"Citation": "Ali H.F.M., El-Ella F.M.A., Nasr N.F. Screening of chemical analysis, antioxident antimicrobial and antitumor activity of essential oil of oleander (Nerium oleander) flower. Int J Biol Chem. 2010;4(4):190\u2013202."}, {"Citation": "Smith J.A., Madden T., Vijjeswarapu M., Newman R.A. Inhibition of export of fibroblast growth factor-2 (FGF-2) from the prostate cancer cell lines PC3 and DU145 by Anvirzel and its cardiac glycoside component, oleandrin. Biochem Pharmacol. 2001;62(4):469\u2013472. doi: 10.1016/s0006-2952(01)00690-6.", "ArticleIdList": ["10.1016/s0006-2952(01)00690-6", "11448457"]}, {"Citation": "Afaq F., Saleem M., Aziz M.H., Mukhtar H. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion markers in CD-1 mouse skin by oleandrin. Toxicol Appl Pharmacol. 2004;195(3):361\u2013369.", "ArticleIdList": ["15020199"]}, {"Citation": "Newman R.A., Yang P., Hittelman W.N., Lu T., Ho D.H., Ni D., et al. Oleandrin-mediated oxidative stress in human melanoma cells. J\u00a0Exp Therapeut Oncol. 2006;5(3):167\u2013181.", "ArticleIdList": ["16528968"]}, {"Citation": "Ghoneum M., Ozel H.Z., Gollapudi S. Nerium oleander leaf extract sensitizes human burkett cell lymphoma (Raji) to human cytotoxicity mediated by natural killer cells. Clin Immunol. 2006;119(SUPP):S188."}, {"Citation": "Turan N., Akg\u00fcn-Dar K., Kuruca S.E., Kili\u00e7aslan-Ayna T., Seyhan V.G., Atasever B., et al. Cytotoxic effects of leaf, stem and root extracts of Nerium oleander on leukemia cell lines and role of the p-glycoprotein in this effect. J\u00a0Exp Therapeut Oncol. 2006;6:31\u201338.", "ArticleIdList": ["17228522"]}, {"Citation": "Newman R.A., Kondo Y., Yokoyama T., Dixon S., Cartwright C., Chan D., et al. Autophagic cell death of human pancreatic tumor cells mediated by oleandrin, a lipid-soluble cardiac glycoside. Integr Cancer Ther. 2007;6(4):254\u2013264.", "ArticleIdList": ["18048883"]}, {"Citation": "Fiebig H.H., Kelter G., Maier A., Metz T., Rashan L.J. Breastin a natural product from Nerium Oleander exhibits high activity in a panel of human tumor cell lines. Cancer Res. 2013;73(8 Suppl):5572. doi: 10.1158/1538-7445.AM2013-5572.", "ArticleIdList": ["10.1158/1538-7445.AM2013-5572"]}, {"Citation": "Simon S.E., Jayakumar F.A. Antioxidant activity and anticancer study on phytochemicals extract from tubers of Gloriosa superba against human cancer cell (Hep-G2) Res Rev: J Pharmacogn Phytochem. 2016;4(4):7\u201312."}, {"Citation": "Luc, Amerikalei, Sandra, Heide, Rica, Hondstraat, et al. World Intellectual Property Organization; 22 September 2016. Extracts, compositions and use thereof, International Application Published Under The Patent Cooperation Treaty (PCT), WO 2016/146562 Al."}, {"Citation": "Khan Haroon, Khan Murad Ali, Hussan Iqbal. Enzyme inhibition activities of the extracts from rhizomes of Gloriosa superba Linn (Colchicaceae) J\u00a0Enzym Inhib Med Chem. 2007;22(6):722\u2013725. doi: 10.1080/14756360601164853.", "ArticleIdList": ["10.1080/14756360601164853", "18237025"]}, {"Citation": "Budhiraja A., Nepali K., Sapra S., Gupta S., Kumar S., Dhar K.L. Bioactive metabolites from an endophytic fungus of Aspergillus species isolated from seeds of Gloriosa superba Linn. Med Chem Res. 2013;22:323\u2013329. doi: 10.1007/s00044-012-0032-z.", "ArticleIdList": ["10.1007/s00044-012-0032-z"]}, {"Citation": "Shah Kautuk Kumar, Vidya Sagar G. Phytochemical and pharmacological evaluation of Gloriosa superba. J\u00a0Drug Deliv Therapeut. 2015;5(4):27\u201342."}, {"Citation": "Budchart Prapaphan, Khamwut Ariya, Sinthuvanich Chomdao, Ratanapo Sunanta, Poovorawan Yong, Nattanan Panjaworayan, et al. Partially purified Gloriosa superba peptides inhibit colon cancer cell viability by inducing apoptosis through p53 upregulation. Am J Med Sci. 2017;354(4):423\u2013429.", "ArticleIdList": ["29078848"]}, {"Citation": "Jayakumar F.A., Simon S.E., Yan Y.W., Yap P.W. Characteristic and optimized use of bioactive compounds from Gloriosa superba and albizia amara with apoptotic effect on hepatic and squamous skin carcinoma. Int J Pharmaceut Sci Res. 2018;9(5):1769\u20131778."}, {"Citation": "Srikanth Murthy K.R., Cikitsita Vata Vyadhi, Stana Cikitsita. vol. 508. Chaukhamba Krishnadas Academy; Varanasi: 2012. pp. 58\u201361. (Vag Bhata's Astanga Hridayam). Volume II, [Chapter 21], Verse."}, {"Citation": "Ma Cui-Ying, Liu Wing Keung, Che Chun-Tao. Lignanamides and nonalkaloidal components of Hyoscyamus Niger seeds. J\u00a0Nat Prod. 2002;65(2):206\u2013209.", "ArticleIdList": ["11858758"]}, {"Citation": "Turker A.U., Yildirim A.B., Karakas F.P., Turker H. In\u00a0vitro anti-bacterial and anti tumor efficiency of some traditional plants from Turkey. Indian J Tradit Knowledge. 2018;17(1):50\u201358."}, {"Citation": "Ismeel A.O. Al-Nahrain University- College of Science; Iraq: 2011. Cytogenetic and cytotoxic studies on the effect of phytoinvestigated active compounds of Hyoscyamus Niger (in\u00a0vivo and ex\u00a0vivo) PhD thesis."}, {"Citation": "Deniz U., Hatice G., Fatma G., Ramazan M. Cytotoxic activities of certain medicinal plants on different cancer cell lines. Turk J Pharm Sci. 2017;14(3):222\u2013230. doi: 10.4274/tjps.80299.", "ArticleIdList": ["10.4274/tjps.80299", "PMC7227927", "32454617"]}, {"Citation": "Sharma P.V. Chaukhamba Visvabharathi; Varanasi: 2004. Classical uses of medicinal plants; p. 397."}, {"Citation": "Bigoniya P., Rana A.C. Radioprotective and in-vitro cytotoxic sapogenin from Euphorbia neriifolia (Euphorbiaceae) leaf. Trop J Pharmaceut Res. 2009;8(6):521\u2013530."}, {"Citation": "Patil S B and Magdum C S, Determination of LC50 values of extracts of Euphorbia hirta Linn and Euphorbia neriifolia Linn using brine shrimp lethality assay, Asian J Res Pharm Sci 1(2): April-June 2011; Page 42-43."}, {"Citation": "Upadhyaya C., Kumar A., Sathish S. A\u00a0study on anti-cancer activity of Euphorbia neriifolia (milk hedge) latex. Int J Adv Sci Eng Technol. 2017;5(2):5\u20137. Spl. Issue-2."}, {"Citation": "Pracheta, Sharma V., Paliwal R., Sharma S., Singh L., Janmeda B.S., et al. Chemoprotective activity of hydro-ethanolic extract of Euphorbia neriifolia Linn leaves against DENA-induced liver carcinogenesis in mice. Biol Med. 2011;3(2):36\u201344. Special Issue."}, {"Citation": "Janmeda P, Sharma V, Singh L, Paliwal R, Sharma S, Yadav S, et\u00a0al, Chemopreventive effect of hydroethanolic extract of Euphorbia neriifolia leaves against DENA-induced renal carcinogenesis in mice, Asian Pac J Cancer Prev APJCP, 12, 677-683.", "ArticleIdList": ["21627363"]}, {"Citation": "Li J.C., Feng X.Y., Liu D., Zhang Z.J., Chen X.Q., Li R.T., et al. Diterpenoids from Euphorbia neriifolia and their related anti-HIV and cytotoxic activity. Chem Biodivers. 2019;16", "ArticleIdList": ["31755643"]}, {"Citation": "Chodoeva A., Bosc J.-J., Robert J. Aconitum alkaloids and biological activities. Natural Products. 2013:1503\u20131523. doi: 10.1007/978-3-642-22144-6_191.", "ArticleIdList": ["10.1007/978-3-642-22144-6_191"]}, {"Citation": "Feng H.T., Zhao W.W., Lu J.J., Wang Y.T., Chen X.P. Hypaconitine inhibits TGF-\u03b21-induced epithelial\u2013mesenchymal transition and suppresses adhesion, migration, and invasion of lung cancer A549 cells. Chin J Nat Med. 2017;15(6):427\u2013435.", "ArticleIdList": ["28629532"]}, {"Citation": "Chodoeva A., Bosc J.J., Guillon J., Costet P., Decendit A., M\u00e9rillon J.M., et al. Hemisynthesis and antiproliferative properties of mono-[O-(14-benzoylaconine-8-yl)]esters and bis-[O-(14-benzoylaconine-8-yl)]esters. Eur J Med Chem. 2012;54:343\u2013351.", "ArticleIdList": ["22673143"]}, {"Citation": "Chodoeva A., Bosc J.J., Lartigue L., Guillon J., Auzanneau C., Costet P., et al. Antitumor activity of semisynthetic derivatives of Aconitum alkaloids. Invest N Drugs. 2014;32(1):60\u201367. doi: 10.1007/s10637-013-9986-z.", "ArticleIdList": ["10.1007/s10637-013-9986-z", "23761053"]}, {"Citation": "Bensky D., Gamble A. Eastland Press; Seattle: 1986. Chinese herbal medicine; p. 646."}, {"Citation": "Cai B.C., Wang T.S., Kurokawa M., Shiraki K., Hattori M. Cytotoxicities of alkaloids from processed and unprocessed seeds of Strychnos nux-vomica. Acta Pharmacol Sin. 1998;19:425\u2013428.", "ArticleIdList": ["10375801"]}, {"Citation": "Deng X., Yin F., Xiaoyu L., Cai B., Yin W. The apoptotic effect of brucine from the seed of Strychnos nux-vomica on human hepatoma cells is mediated via Bcl-2 and Ca2+ involved mitochondrial pathway. Toxicol Sci. 2006;91:59\u201369.", "ArticleIdList": ["16443926"]}, {"Citation": "Rao P.S., Ramanadham M., Prasad M.N. Anti-proliferative and cytotoxic effects of Strychnos nux-vomica root extract on human multiple myeloma cell line-RPMI 8226. Food Chem Toxicol. 2009;47:283\u2013288.", "ArticleIdList": ["19027818"]}, {"Citation": "Serasanambati M., Chilakapati S.R., Manikonda P.K., Kanala J.R., Chilakapati D.R. Anticancer effects of brucine and gemcitabine combination in MCF-7 human breast cancer cells. Nat Prod Res: Formerly Nat Prod Lett. 2014 doi: 10.1080/14786419.2014.951932.", "ArticleIdList": ["10.1080/14786419.2014.951932", "25167883"]}, {"Citation": "Khan M., Garg A., Srivastava S.K., MDarokar M.P. A\u00a0cytotoxic agent from Strychnos nux-vomica and biological evaluation of its modified analogues. Med Chem Res. 2012;21:2975\u20132980."}, {"Citation": "Rao P.S., Ramanadham M., Prasad M.N. Anti-proliferative effects of Syrychnos nux-vomica root extract on human multiple myeloma cell line- RPMI 8226. Food Chem Toxicol. 2009;47(2):283.", "ArticleIdList": ["19027818"]}, {"Citation": "Eldahshan O.A., Abdel-Daim M.M. Phytochemical study, cytotoxic, analgesic, antipyretic and anti-inflammatory activities of Strychnos nux-vomica. Cytotechnology. 2015;67:831\u2013844.", "ArticleIdList": ["PMC4545432", "24711053"]}, {"Citation": "Anajwala C.C., Patel R.M., Dakhara S.L., Jariwala J.K. In\u00a0vitro cytotoxicity study of Agave americana, Strychnos nuxvomica and Areca catechu extracts using MCF-7 cell line. J\u00a0Adv Pharm Technol Res (JAPTR) 2010;1(2):245\u2013252.", "ArticleIdList": ["PMC3255432", "22247852"]}, {"Citation": "Zheng L., Wang X., Luo W., Zhan Y., Zhang Y. Brucine, an effective natural compound derived from nux-vomica, induces G1 phase arrest and apoptosis in LoVo cells. Food Chem Toxicol. 2013;58:332\u2013339.", "ArticleIdList": ["23688861"]}, {"Citation": "Rao P.S., Prasad M.N.V. Strychnos nux-vomica root extract induces apoptosis in the human multiple myeloma cell line\u2014U266B1. Cell Biochem Biophys. 2013;66:443\u2013450.", "ArticleIdList": ["23250582"]}, {"Citation": "Agrawal S.S., Saraswati S., Mathur R., Pandey M. Cytotoxic and antitumor effects of brucine on Ehrlich ascites tumor and human cancer cell line. Life Sci. 2011;89:147\u2013158.", "ArticleIdList": ["21684292"]}, {"Citation": "Saraswati S., Agrawal S.S. Brucine, an indole alkaloid from Strychnos nux-vomica attenuates VEGF-induced angiogenesis via inhibiting VEGFR2 signaling pathway in\u00a0vitro and in\u00a0vivo. Cancer Lett. 2013;332(1):83\u201393. doi: 10.1016/j.canlet.2013.01.012.", "ArticleIdList": ["10.1016/j.canlet.2013.01.012", "23348691"]}, {"Citation": "Shu G., Mi X., Cai J., Zhang X., Yin W., Yang X., et al. An alkaloid from seeds of Strychnos nux-vomica Linn., represses hepatocellular carcinoma cell migration and metastasis: the role of hypoxia inducible factor 1 pathway. Toxicol Lett. 2013;222(2):91\u2013101. doi: 10.1016/j.toxlet.2013.07.024.", "ArticleIdList": ["10.1016/j.toxlet.2013.07.024", "23933019"]}, {"Citation": "Saraswati Sarita, Alhaider Abdulqader, Sunder Shyam. Anticarcinogenic effect of brucine in diethylnitrosamine initiated and phenobarbital-promoted hepatocarcinogenesis in rats. Chem Biol Interact. 2013;206:214\u2013221. doi: 10.1016/j.cbi.2013.09.012.", "ArticleIdList": ["10.1016/j.cbi.2013.09.012", "24060683"]}, {"Citation": "Deng X.K., Yin W., Li W.D., Yin F.Z., Lu X.Y., Zhang X.C., et al. The anti-tumor effects of alkaloids from the seeds of Strychnos nux-vomica on HepG2 cells and its possible mechanism. J\u00a0Ethnopharmacol. 2006 Jun;106(2):179\u2013186. doi: 10.1016/j.jep.2005.12.021.", "ArticleIdList": ["10.1016/j.jep.2005.12.021", "16442763"]}, {"Citation": "Li M., Li P., Zhang M., Ma F. Brucine suppresses breast cancer metastasis via inhibiting epithelial mesenchymal transition and matrix metalloproteinases expressions. Chin J Integr Med. 2018;24(1):40\u201346. doi: 10.1007/s11655-017-2805-1.", "ArticleIdList": ["10.1007/s11655-017-2805-1", "28795388"]}, {"Citation": "Li S., Wang X.P. In\u00a0vitro and in\u00a0vivo evaluation of novel NGR-modified liposomes containing brucine. Int J Nanomed. 2017;12:5797\u20135804.", "ArticleIdList": ["PMC5565249", "28860749"]}, {"Citation": "Anwar S., Ahmad B., Subhan M., Gul W., Islam N.U. Biological and pharmacological properties of Aconitum chasmanthum. J\u00a0Biol Sci. 2003;3(11):989\u2013993."}, {"Citation": "Maurya S.K., Seth A., Laloo D., Singh N.K., Gautam D.N., Singh A.K. \u015aodhana: an Ayurvedic process for detoxification and modification of therapeutic activities of poisonous medicinal plants. Ancient Sci Life. 2015 Apr-Jun;34(4):188\u2013197. doi: 10.4103/0257-7941.160862. PMID: 26283803; PMCID: PMC4535066.", "ArticleIdList": ["10.4103/0257-7941.160862", "PMC4535066", "26283803"]}, {"Citation": "WHO Guidelines on the prevention of toxic exposures education and public awareness activities international programme on chemical safety UNEP. Int Program Chem Saf. 2004;1\u2013116"}, {"Citation": "Series-i G. Central Council For Research In Ayurvedic Sciences, Ministry of AYUSH, Government o f India; New Delhi: 2018. Guidelines series-I general Guidelines for drug development of ayurvedic formulations."}, {"Citation": "Ventola C.L. Current issues regarding Complementary and Alternative Medicine (cam) in the United States - Part 2: regulatory and safety concerns and proposed governmental policy changes with respect to dietary supplements. P\u00a0T. 2010;35:514\u2013522.", "ArticleIdList": ["PMC2957745", "20975811"]}, {"Citation": "Ramadoss Malathi Seshasayee Konda, Koumaravelou Kailasam. Regulatory compliance of herbal medicines \u2013 a review. Int J Res Pharm Sci. 2019;10:3127\u20133135. doi: 10.26452/ijrps.v10i4.1609.", "ArticleIdList": ["10.26452/ijrps.v10i4.1609"]}, {"Citation": "List of banned or restricted herbal ingredients for medicinal use. Guidance-Banned and restricted herbal ingredients. Medicines and Healthcare products Regulatory Agency. 2014. https://www.gov.uk/government/publications/list-of-banned-or-restricted-herbal-ingredients-for-medicinal-use/banned-and-restricted-herbal-ingredients"}, {"Citation": "Institute N.C.  2021. Drugs approved for different types of cancer.https://www.cancer.gov/about-cancer/treatment/drugs/cancer-type"}, {"Citation": "Institute NC. Topotecan hydrochloride n.d. https://www.cancer.gov/about-cancer/treatment/drugs/topotecanhydrochloride."}, {"Citation": "Garc\u00eda-Aranda M., P\u00e9rez-Ruiz E., Redondo M. Bcl-2 inhibition to overcome resistance to chemo- and immunotherapy. Int J Mol Sci. 2018;19:3950. doi: 10.3390/ijms19123950.", "ArticleIdList": ["10.3390/ijms19123950", "PMC6321604", "30544835"]}, {"Citation": "Martino E., Casamassima G., Castiglione S., Cellupica E., Pantalone S., Papagni F., et al. Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead. Bioorg Med Chem Lett. 2018;28:2816\u20132826. doi: 10.1016/j.bmcl.2018.06.044.", "ArticleIdList": ["10.1016/j.bmcl.2018.06.044", "30122223"]}, {"Citation": "Li J., Yuan J. Caspases in apoptosis and beyond. Oncogene. 2008;27:6194\u20136206. doi: 10.1038/onc.2008.297.", "ArticleIdList": ["10.1038/onc.2008.297", "18931687"]}, {"Citation": "Singh R.H. An assessment of the ayurvedic concept of cancer and a new paradigm of anticancer treatment in Ayurveda. J\u00a0Alternative Compl Med. 2002 Oct;8(5):609\u2013614. doi: 10.1089/107555302320825129. PMID: 12470442.", "ArticleIdList": ["10.1089/107555302320825129", "12470442"]}, {"Citation": "Gundeti Manohar Saheb, Rammanohar Puthiyedath, Bhat Sulochana G., Narayanam Srikanth. Ayurveda in cancer care in India: scope, challenges, and suggested approaches. J\u00a0Alternative Compl Med. 2018;24(9\u201310):1023\u20131024. doi: 10.1089/acm.2018.0161.", "ArticleIdList": ["10.1089/acm.2018.0161", "30247971"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "10", "Day": "5"}, {"Year": "2021", "Month": "12", "Day": "13"}, {"Year": "2022", "Month": "1", "Day": "11"}, {"Year": "2022", "Month": "6", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "7", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "6", "Day": "6", "Hour": "13", "Minute": "5"}, {"Year": "2022", "Month": "5", "Day": "31"}], "PublicationStatus": "ppublish", "ArticleIdList": ["35661925", "PMC9163510", "10.1016/j.jaim.2022.100545", "S0975-9476(22)00004-3"]}}], "PubmedBookArticle": []}